Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
Conditions: Tuberculosis; HIV I Infection; Sepsis Interventions: Other: Immediate anti-TB therapy; Other: Sepsis-specific dose anti-TB therapy Sponsors: University of Virginia; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Allergy | Allergy & Immunology | Infectious Diseases | Research | Tuberculosis